Updates

October 29, 2026 To, To, Listing Department, The National Stock Exchange of BSE Limited India Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Subject: Intimation of receipt of 'In-Principle' Approval under Regulation 30 of SEBI (LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received 'In-Principle' approval from the NSE and BSE for the proposed issuance of 8,05,35,651 equity shares of Rs. 2/- each, pursuant to the proposed share swap, on a preferential basis, in terms of Chapter V of the SEBI (ICDR) Regulations, 2018 and in terms of the following letters received from each of them: 01. National Stock Exchange of India Limited, vide letter no. NSE/LIST/56913 dated 28/10/2026; and 02. BSE Limited, vide letter no. LOD/PREF/DA/FIP/1029/2026-27 dated 28/10/2026 Request you to kindly take the same on record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in